logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Love Friend Medical: has no relation with the US listed company Brain Regeneration Technology.

date
15/05/2025
On May 12th, Aipeng Medical replied to investors on the interactive platform, stating that the company has no relation with the U.S. listed company Brain Regeneration Technology.
Latest
2 m ago
has established a new investment company in Shaanxi.
2 m ago
Fitch Ratings: assigns expected "BBB+(EXP)" rating to the proposed issuance of senior unsecured notes by China Everbright Bank's Hong Kong branch
3 m ago
China National Pharmaceutical Group: Guangzhou Guojian Capital Management Co., Ltd. and its affiliated companies have never been authorized to carry out project investments or collaboration promotions in the name of "member companies of China National Pharmaceutical Group".
3 m ago
State-owned China National Pharmaceutical Group Corporation (Sinopharm) released a statement regarding the "Sinopharm Tiantu Zhigu" project, stating that it has recently discovered that Guangzhou Guojian Capital Management Co., Ltd. has been using the name of Sinopharm Group to promote the project and collaborate with local governments. Upon investigation, it was found that Guangzhou Guojian Capital Management Co., Ltd. is a subsidiary of Sinopharm Medicinal Materials Co., Ltd., a company that has been involved in legal disputes and incidents of withholding payments to construction units and rural collective enterprises. Sinopharm Group has previously issued statements clarifying that Sinopharm Medicinal Materials Co., Ltd. and its affiliated companies are not associated with Sinopharm Group or Sinopharm Traditional Chinese Medicine. Sinopharm Group hereby solemnly declares that it has never authorized Guangzhou Guojian Capital Management Co., Ltd. or Sinopharm Medicinal Materials Co., Ltd. and its affiliated companies to conduct any form of project investment or cooperation promotion in the name of "China National Pharmaceutical Group Corporation," "China National Pharmaceutical Group," "Sinopharm Group," or "member companies of Sinopharm Group." Sinopharm Group reserves the right to pursue legal responsibility for anyone who impersonates Sinopharm Group or damages its reputation.
3 m ago
Food stocks fluctuated and rose, Xiwang Food rose limit up, Aizhi Moyu rose over 10%, Kangbit, Ximai Food, Knight Dairy, Andeli and other stocks rose over 5%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.